Record ownership
Each page names which system owns the record, which team acts, and what Clinistack treats as operational evidence.
Organizations
Sponsors, CROs, sites, biotech teams, and academic research groups share the same study reality. Clinistack gives each group the control surface that matches its work without fragmenting the record.
Organization map
Five work views, one study record.Teams
One study can mean Sponsor oversight, CRO delivery, site workload, lean biotech control, or academic research operations. The record stays coherent while the work surface changes.
Sponsor oversight, CRO accountability, amendment impact, safety context, vendor evidence, and inspection readiness.
Repeatable delivery, Sponsor-specific requirements, country variation, monitoring follow-up, RBM work, and client-visible evidence.
Coordinator queues, DOA and training currency, consent-version context, eISF/eTMF exchange, source evidence, and monitor follow-up.
Lean Sponsor control, CRO-heavy trial oversight, vendor stack visibility, safety awareness, and a model that survives pivotal scale.
IRB cadence, EHR/source realities, grant constraints, coordinator turnover, and multi-study PI accountability.
First rollout
We will review the product path, system context, owners, evidence, and rollout approach that fit the trial work in front of you.